Avara Liscate Pharmaceutical Services is a finished-dose manufacturer based in Italy. It appears in 6 regulatory filings across 4 regulators, without an active US DMF or CEP on file. Its filings concentrate with EDE (AE), NPRA (MY) and ARCSA (EC). Its GMP standing is certified by ANVISA (Brazil), EMA and MFDS (Korea), among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 9 June 2023 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Milan, United Arab Emirates | Not on file |
| LISCATE, Italy | Not on file |
| Liscate, Italy | Not on file |
| Italy, Italy | 3004640070 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| EDE (AE) | 2 | None |
| NPRA (MY) | 2 | None |
| ARCSA (EC) | 1 | None |
| MINSA (CR) | 1 | None |
| ANVISA (Brazil) | None | 3 |
| EMA | None | 2 |
| MFDS (Korea) | None | 2 |
| EAEU_EEC | None | 1 |
| US FDA | None | 1 |
Choose your molecules and target markets. Avara Liscate Pharmaceutical Services comes back tiered against every other supplier able to file there.
Start for free